FMF prenatal test - without ultrasound and risk assessment

• The material for testing is blood.
• The patient does not need to fast. It is recommended to drink a glass of water approximately 30 minutes before the examination.

Prenatal testing performed in the first trimester of pregnancy (between 11 and 14 weeks of pregnancy) determines the risk of fetal chromosomal aberrations (Down syndrome, Edwards syndrome, Patau syndrome, neural tube defects, and others).
The test includes an assessment of biochemical parameters in the mother's blood: PAPP-A protein concentration and free beta-hCG subunit concentration. Biochemical marker levels are measured in blood serum using FMF-certified tests.
An integral part of the test is the estimation of the risk of fetal genetic defects using statistical software certified by the Polish Gynecological Society - Ultrasound Section and the FMF Fetal Medicine Foundation. The risk assessment is performed by the ordering FMF-certified physician based on the results of the pregnancy ultrasound and biochemical parameters.

Enter one-time code:Show
Invalid code entered. Please try again.